Celanese to Construct World-Scale Vinyl Acetate Monomer Plant in China

Celanese Corporation, announced that it will build a 300,000 metric ton, world-scale vinyl acetate monomer (VAM) plant at the company’s Nanjing, China chemical complex. The plant is expected to be operational in late 2007 or early 2008.

“As the world’s leading producer of VAM and other acetyl-based products, we believe it is important to have a manufacturing presence in the world’s fastest growing region to supply our customers with a reliable, locally produced product,” said David Weidman, president and chief executive officer. “This investment is consistent with our strategy to maintain our number one position in the VAM market.”

The VAM plant will receive acetic acid, a key raw material, from Celanese’s 600,000 metric ton acetic acid plant in Nanjing, which will begin commercial sales in early 2007. The company currently operates seven plants around the world to produce VAM, which is used to make such products as paints, coatings, adhesives and fibers.

The company also announced today that in 2006 it will begin implementation of its next generation of VAM technology called VAntage PlusTM. The new technology will further improve production efficiency and lower operating costs as it is phased into Celanese’s VAM units over the next several years. In 2005, Celanese completed implementation of its VAntageTM technology in the last of its six ethylene-based VAM units. VAntageTM not only enhanced production efficiency, but also increased Celanese’s overall VAM production capacity by 265,000 metric tons, equivalent to a world-scale unit, at 10 to 15% of the cost of building a grass-roots unit.

http://www.celanese.com

15th December 2005

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.